Quality & Patient Safety

Banning prescription drug ads could cost $10B

Patient Safety Monitor Alert, August 3, 2005

Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!

A ban on prescription drug ads proposed by Senate Majority Leader Bill Frist could cost the industry $10 billion dollars. Industry leaders say the commercials are an effective public service announcement, informing them of how to ease pain and suffering, according to a report on www.cnn.com.

The senate leader called for a two-year moratorium on the ads, saying research has shown that the ads have led to the inappropriate prescribing of medicines that aren't needed for patients. Many patients hear about the premium-brand drug and demand it from their physician, even when a cheaper, generic medication is more appropriate.

Proponents of the advertising say the ads raise awareness of medical conditions, and that gets patients to go and visit a physician.

To read the complete report, click here.



Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!

    Patient Safety Monitor
  • Patient Safety Monitor

    As part of your Patient Safety Monitor membership, you'll receive Briefings on Patient Safety. In this 12-page monthly...

  • Patient Safety Monitor Alert

    This e-mail newsletter provides healthcare professionals with the latest patient safety news, while offering useful...

  • Patient Safety Quality Monthly

    Ken Rohde, Senior Consultant for The Greeley Company with over 25 years of experience in quality management. His roles in...

  • Occurrence Reporting:

    Take advantage of the information occurrence reports provide and make sustainable enhancements at your facility. Expert...

Most Popular

Related Articles